We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt.

Oncogene | May 18, 2006

Proapoptotic nuclear receptor family member Nur77 translocates from the nucleus to the mitochondria, where it interacts with Bcl-2 to trigger apoptosis. Nur77 translocation is induced by certain apoptotic stimuli, including the synthetic retinoid-related 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN)/CD437 class. In this study, we investigated the molecular mechanism by which AHPN/CD437 analog (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induces Nur77 nuclear export. Our results demonstrate that 3-Cl-AHPC effectively activated Jun N-terminal kinase (JNK), which phosphorylates Nur77. Inhibition of JNK activation by a JNK inhibitor suppressed 3-Cl-AHPC-induced Nur77 nuclear export and apoptosis. In addition, several JNK upstream activators, including the phorbol ester TPA, anisomycin and MAPK kinase kinase-1 (MEKK1), phosphorylated Nur77 and induced its nuclear export. However, Nur77 phosphorylation by JNK, although essential, was not sufficient for inducing Nur77 nuclear export. Induction of Nur77 nuclear export by MEKK1 required a prolonged MEKK1 activation and was attenuated by Akt activation. Expression of constitutively active Akt prevented MEKK1-induced Nur77 nuclear export. Conversely, transfection of dominant-negative Akt or treatment with a phosphatidylinositol 3-kinase (PI3-K) inhibitor accelerated MEKK1-induced Nur77 nuclear export. Furthermore, mutation of an Akt phosphorylation residue Ser351 in Nur77 abolished the effect of Akt or the PI3-K inhibitor. Together, our results demonstrate that both activation of JNK and inhibition of Akt play a role in translocation of Nur77 from the nucleus to the cytoplasm.

Pubmed ID: 16434970 RIS Download

Mesh terms: Adamantane | Anisomycin | Apoptosis | Cell Line, Tumor | Cell Nucleus | Cinnamates | DNA-Binding Proteins | Enzyme Activation | Flavonoids | Humans | Imidazoles | JNK Mitogen-Activated Protein Kinases | MAP Kinase Kinase 7 | MAP Kinase Kinase Kinase 1 | Mutagenesis, Site-Directed | Nuclear Receptor Subfamily 4, Group A, Member 1 | Phosphatidylinositol 3-Kinases | Phosphorylation | Protein Processing, Post-Translational | Protein Transport | Proto-Oncogene Proteins c-akt | Proto-Oncogene Proteins c-bcl-2 | Pyridines | Receptors, Cytoplasmic and Nuclear | Receptors, Steroid | Recombinant Fusion Proteins | Tetradecanoylphorbol Acetate | Transcription Factors

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA109345
  • Agency: NCI NIH HHS, Id: CA87000
  • Agency: NIGMS NIH HHS, Id: GM60544

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.